← Leaderboards
Jesus Antonio Araujo
University Of California Los Angeles
$8,247,283
Attributed
$9,551,066
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,551,066 · 6
By mechanism
R01$8,973,566 · 4
R21$423,500 · 1
R56$154,000 · 1
Top collaborators
- Tzung K Hsiai7 shared
- Yifang Zhu2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Tzung K Hsiai$18,151,559
- Andre Elias Nel$21,296,649
- Srinivasa Reddy$11,348,036
- Alan M Fogelman$11,850,800
- Paivi Pajukanta$18,094,651
Others in their field
Top investigators on “Exposure To”
- Chanza Baytop · Westat, Inc.$271,217,917
- Dennis R. Burton · Scripps Research Institute$265,781,207
- Myron S Cohen · Family Health International$253,611,624
- Wafaa M. El-Sadr · Columbia University Health Sciences$253,611,624
- George R Seage · Abt Associates, Inc.$221,990,872
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$151,998,810
Research focus
Exposure ToAtherosclerosisTissuesPathway InteractionsDiesel ExhaustCardiovascular SystemLeadParticulate MatterUltrafine ParticlePlasmaParticleLipidsBlood VesselsKnockout MiceAir PollutionOxidative StressBloodInflammatoryLipoproteinsToxic EffectEpidemiologyMorbidity - Disease RateDesignCessation Of Life
Grant awards (25)
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity$504,912
R01 · FY2025 · ES · contact PI
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles$391,155
R01 · FY2025 · ES · contact PI
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity$513,320
R01 · FY2024 · ES · contact PI
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles$393,299
R01 · FY2024 · ES · contact PI
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity$521,557
R01 · FY2023 · ES · contact PI
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles$395,381
R01 · FY2023 · ES · contact PI
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity$362,050
R01 · FY2023 · ES · contact PI
Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity$543,455
R01 · FY2022 · ES · contact PI
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles$397,402
R01 · FY2022 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$375,314
R01 · FY2022 · ES · contact PI
Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles$398,606
R01 · FY2021 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$388,616
R01 · FY2021 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$67,266
R01 · FY2021 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$505,331
R01 · FY2020 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$48,046
R01 · FY2020 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$391,421
R01 · FY2019 · ES · contact PI
Role of Intestinal Microbiota in Dyslipidemia and Atherosclerosis Induced by Ambient Ultrafine Particles$408,073
R01 · FY2018 · ES · contact PI
Air Pollution and Cardiovascular Diseases: Identification of Novel Biomarkers$231,000
R21 · FY2016 · ES
Air Pollution and Cardiovascular Diseases: Identification of Novel Biomarkers$192,500
R21 · FY2015 · ES
Effects of particulate air pollution on HDL function and athersclerosis$154,000
R56 · FY2014 · ES · contact PI
Effects of particulate air pollution on HDL function and atherosclerosis$405,453
R01 · FY2013 · ES · contact PI
Effects of particulate air pollution on HDL function and atherosclerosis$417,302
R01 · FY2012 · ES · contact PI
Effects of particulate air pollution on HDL function and atherosclerosis$423,146
R01 · FY2011 · ES · contact PI
Effects of particulate air pollution on HDL function and atherosclerosis$560,190
R01 · FY2010 · ES · contact PI
Effects of particulate air pollution on HDL function and atherosclerosis$562,271
R01 · FY2009 · ES · contact PI